News of the index components OMX Copenhagen 20

Index

OMXC20

DK0016268840

Market Closed - Nasdaq Copenhagen 11:05:00 2024-07-09 am EDT			5-day change	1st Jan Change
2,820 ^PTS	-1.50%		-1.68%	+23.48%

Jul. 02	Indices: CAC relaxes, Merval soars
Jun. 05	Nordic Shares Moved Upward Wednesday; Crayon Group Topped Leaders	DJ

News of the index components

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Major shareholder announcement NSIS B	Jun. 26	AQ
AlphaValue/Baader Europe Downgrades Novo Nordisk to Add from Buy, Raises PT NOVO B	Jun. 26	MT
Danske Bank Lifts FY24 Net Profit Guidance DANSKE	Jun. 26	MT
Danske Bank raises 2024 profit forecast DANSKE	Jun. 26	RE
Danske Bank A/S revises 2024 net profit upwards. Now expects a net profit in the range of DKK 21-23 billion DANSKE	Jun. 26	GL
Danske Bank A/S Provides Loan Impairment Charges for the Full Year 2024 DANSKE	Jun. 26	CI
Danske Bank A/S Revises Earnings Guidance for 2024 DANSKE	Jun. 26	CI
Demant Flags Delay in Completion of Communications Business' Strategic Review DEMANT	Jun. 26	MT
Demant A/S: Updated timeline for the strategic review of Communications DEMANT	Jun. 26	AQ
China Approves Novo Nordisk's Injection for Long-term Weight Management NOVO B	Jun. 26	MT
Singapore port congestion shows global ripple impact of Red Sea attacks MAERSK B	Jun. 26	RE
Singapore port congestion shows global ripple impact of Red Sea attacks MAERSK B	Jun. 25	RE
Health Care Up as Novo Nordisk Gets China OK -- Health Care Roundup NOVO B	Jun. 25	DJ
Trending : Novo Nordisk's Wegovy Weight-Loss Drug Gets Chinese Approval NOVO B	Jun. 25	DJ
MEDIA-Novo weight-loss drug Saxenda poses risk to bone health, study finds - Bloomberg News NOVO B	Jun. 25	RE
Novo Nordisk Wins Weight-Loss Drug Approval in China; Plans $4.1 Billion US Facility NOVO B	Jun. 25	MT
Danske Bank A/S : Insider transaction disclosure no. 65 DANSKE	Jun. 25	PU
Sector Update: Health Care NOVO B	Jun. 25	MT
Danske Bank A/S, transactions by persons discharging managerial responsibilities DANSKE	Jun. 25	GL
Novo Nordisk's Wegovy Weight-Loss Drug Gets Approval in China NOVO B	Jun. 25	MT
Novo Nordisk's Wegovy Weight-Loss Drug Gets Approval in China NOVO B	Jun. 25	DJ
NOVO NORDISK : Deutsche Bank remains its Buy rating NOVO B	Jun. 25	ZD
Novo Nordisk says its Wegovy weight-loss drug wins China approval NOVO B	Jun. 25	RE
Novo Nordisk: new plant project in North Carolina NOVO B	Jun. 25	CF
Novo Nordisk says Semaglutide approved for long-term weight management in China NOVO B	Jun. 25	RE
NOVO NORDISK SEMAGLUTIDE APPROVED FOR LONG-TERM WEIGHT MANAGEMEN… NOVO B	Jun. 25	RE
Novo Nordisk Plans New $4.1 Billion US Manufacturing Facility NOVO B	Jun. 24	MT
Health Care Up on Defensive Demand -- Health Care Roundup NOVO B	Jun. 24	DJ
Sector Update: Health Care Stocks Rise in Late Afternoon Trading NOVO B	Jun. 24	MT
Sector Update: Health Care NOVO B	Jun. 24	MT
Novo Nordisk to Invest $4.1 Billion in New Facility to North Carolina NOVO B	Jun. 24	DJ
Novo Nordisk CEO's testimony before US Senate panel set for Sept. 24 NOVO B	Jun. 24	RE
Novo Nordisk to Invest $4.1 Billion in North Carolina Facility NOVO B	Jun. 24	MT
Novo Nordisk Plans $4.1 Billion Investment in North Carolina Facility NOVO B	Jun. 24	MT
Novo Nordisk to Invest $4.1 Billion in North Carolina Facility NOVO B	Jun. 24	MT
Novo Nordisk Invests $4.1 Billion in North Carolina Facility NOVO B	Jun. 24	MT
Novo Nordisk announces 4.1 billion USD investment to expand US manufacturing capacity adline NOVO B	Jun. 24	GL
Novo Nordisk Announces USD 4.1 Billion Investment to Expand US Manufacturing Capacity Adline NOVO B	Jun. 24	CI
Wegovy-maker Novo Nordisk to spend $4.1 bln to boost US manufacturing NOVO B	Jun. 24	RE
Teva launches generic version of Novo Nordisk's diabetes drug Victoza NOVO B	Jun. 24	RE